Ultrasensitive Detection of C-Reactive Protein by a Novel Nanoplasmonic Immunoturbidimetry Assay.

C-reactive protein nanophotonics one-step detection rapid diagnostics surface plasmon resonance ultrasensitive detection

Journal

Biosensors
ISSN: 2079-6374
Titre abrégé: Biosensors (Basel)
Pays: Switzerland
ID NLM: 101609191

Informations de publication

Date de publication:
02 Nov 2022
Historique:
received: 03 10 2022
revised: 28 10 2022
accepted: 29 10 2022
entrez: 10 11 2022
pubmed: 11 11 2022
medline: 15 11 2022
Statut: epublish

Résumé

Nanotechnology has attracted much attention, and may become the key to a whole new world in the fields of food, agriculture, building materials, machinery, medicine, and electrical engineering, because of its unique physical and chemical properties, including high surface area and outstanding electrical and optical properties. The bottom-up approach in nanofabrication involves the growth of particles, and we were inspired to propose a novel nanoplasmonic method to detect the formation of nanoparticles in real time. This innovative idea may contribute to the promotion of nanotechnology development. An increase in nanometer particle size leads to optical extinction or density (OD)-value changes in our nanosensor chip at a specific wavelength measured in a generic microplate reader. Moreover, in applying this method, an ultrasensitive nanoplasmonic immunoturbidimetry assay (NanoPITA) was carried out for the high-throughput quantification of hypersensitive C-reactive protein (CRP), a well-known biomarker of cardiovascular, inflammatory, and tumor diseases. The one-step detection of the CRP concentration was completed in 10 min with high fidelity, using the endpoint analysis method. The new NanoPITA method not only produced a linear range from 1 ng/mL to 500 ng/mL CRP with the detection limit reduced to 0.54 ng/mL, which was an improvement of over 1000 times, with respect to regular immunoturbidity measurement, but was also effective in blood detection. This attractive method, combined with surface plasmon resonance and immunoturbidimetry, may become a new technology platform in the application of biological detection.

Identifiants

pubmed: 36354468
pii: bios12110958
doi: 10.3390/bios12110958
pmc: PMC9688280
pii:
doi:

Substances chimiques

C-Reactive Protein 9007-41-4
Biomarkers 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : National Nature Science Foundation of China
ID : 82072735
Organisme : Major Research Program of National Nat-ural Science Foundation of China
ID : 91959107
Organisme : Fundamental Research Funds for the Central Universities
ID : 2019kfyXMPY002
Organisme : National Key R&D Program of China
ID : 2020YFC0861900

Références

Opt Express. 2017 Jul 10;25(14):15967-15976
pubmed: 28789107
Anal Chem. 2001 Jul 15;73(14):3426-31
pubmed: 11476244
N Engl J Med. 1999 Feb 11;340(6):448-54
pubmed: 9971870
Biosens Bioelectron. 2019 Oct 1;142:111494
pubmed: 31319329
Stroke. 2001 Apr;32(4):917-24
pubmed: 11283392
Langmuir. 2010 Sep 7;26(17):13751-4
pubmed: 20672814
Clin Chim Acta. 2006 Sep;371(1-2):163-8
pubmed: 16712824
Anal Chem. 2002 Apr 1;74(7):1624-8
pubmed: 12033254
Sci Rep. 2017 Jan 05;7:40090
pubmed: 28054632
Ecotoxicol Environ Saf. 2020 Sep 15;201:110815
pubmed: 32559688
Respir Res. 2015 May 28;16:62
pubmed: 26018813
Sensors (Basel). 2020 Nov 19;20(22):
pubmed: 33228249
N Engl J Med. 2000 Mar 23;342(12):836-43
pubmed: 10733371
Physiol Rev. 2011 Jul;91(3):795-826
pubmed: 21742788
Vet Res Commun. 1991;15(1):17-24
pubmed: 1904668
Anal Chem. 2005 Nov 15;77(22):7204-11
pubmed: 16285667
Phys Rev Lett. 2001 Feb 5;86(6):1114-7
pubmed: 11178023
N Engl J Med. 1980 Jun 5;302(23):1283-92
pubmed: 6154243
Crit Rev Clin Lab Sci. 1983;18(3):213-60
pubmed: 6339164
ACS Nano. 2020 Jun 23;14(6):6420-6435
pubmed: 32433866
Immunol Res. 2013 May;56(1):131-42
pubmed: 23371836
Biol Bull. 1998 Aug;195(1):1-4
pubmed: 9739546
Chem Rev. 2004 Nov;104(11):5479-502
pubmed: 15535657
Trends Biochem Sci. 1999 Sep;24(9):329-32
pubmed: 10470028
Med Biol Eng Comput. 2010 Oct;48(10):941-3
pubmed: 20844973
Am J Med. 2008 Mar;121(3):219-25
pubmed: 18328306
Trends Biochem Sci. 2003 Nov;28(11):585-92
pubmed: 14607088
Biosens Bioelectron. 2017 Jul 15;93:176-181
pubmed: 27638106
Sensors (Basel). 2017 Jul 02;17(7):
pubmed: 28671600
Clin Chim Acta. 2008 Dec;398(1-2):75-7
pubmed: 18778699
Talanta. 2019 Jul 1;199:164-169
pubmed: 30952241
Anal Chem. 2002 Feb 1;74(3):504-9
pubmed: 11838667
J Clin Invest. 2003 Jun;111(12):1805-12
pubmed: 12813013
Sci Rep. 2015 May 22;5:10508
pubmed: 26001129
Nat Commun. 2019 Mar 8;10(1):1144
pubmed: 30850633
Biosens Bioelectron. 2015 Mar 15;65:251-6
pubmed: 25461166

Auteurs

Tang Dang (T)

School of Life Science and Technology, Huazhong University of Science and Technology, Wuhan 430022, China.
Department of Bioengineering, The University of Tokyo, 1-3-7 Hongo, Bunkyo-ku, Tokyo 113-8656, Japan.

Zhenyu Li (Z)

Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, 1277 JieFang Avenue, Wuhan 430022, China.

Liyuan Zhao (L)

National Engineering Research Center for Nanomedicine, College of Life Science and Technology, Huazhong University of Science and Technology, Wuhan 430074, China.

Wei Zhang (W)

School of Life Science and Technology, Huazhong University of Science and Technology, Wuhan 430022, China.

Liping Huang (L)

School of Life Science and Technology, Huazhong University of Science and Technology, Wuhan 430022, China.

Fanling Meng (F)

National Engineering Research Center for Nanomedicine, College of Life Science and Technology, Huazhong University of Science and Technology, Wuhan 430074, China.

Gang Logan Liu (GL)

School of Life Science and Technology, Huazhong University of Science and Technology, Wuhan 430022, China.

Wenjun Hu (W)

School of Life Science and Technology, Huazhong University of Science and Technology, Wuhan 430022, China.

Articles similaires

C-Reactive Protein Humans Biomarkers Inflammation
Humans Retrospective Studies Male Critical Illness Female
Humans Male Female Intensive Care Units COVID-19

Classifications MeSH